RecallDepth
Class II Ongoing

Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

This recall is currently active, issued October 8, 2025. It was issued by Zydus Pharmaceuticals (Usa) Inc.

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
September 24, 2025
Posted
October 8, 2025
Recall Number
D-0001-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
912 30-count bottles
Firm Location
Pennington, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot#: E409308, Exp 12/31/2026

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls